EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

miRNAs in Uremic Cardiomyopathy: A Comprehensive Review

Mario D'Agostino, Davide Mauro, Mariateresa Zicarelli, Nazareno Carullo iD, Marta Greco iD, Michele Andreucci iD, Giuseppe Coppolino iD, Davide Bolignano iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065425 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Mario D'Agostino und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology and Dialysis Unit, Department of Medical and Surgical Sciences, University "Magna-Graecia" of Catanzaro, Viale Europa SNC, 88100 Catanzaro…. Hauptthemen laut MEDLINE: MicroRNAs, Cardiomyopathies, RNA, Small Untranslated. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uremic Cardiomyopathy (UCM) is an irreversible cardiovascular complication that is highly pervasive among chronic kidney disease (CKD) patients, particularly in End-Stage Kidney Disease (ESKD) individuals undergoing chronic dialysis. Features of UCM are an abnormal myocardial fibrosis, an asymmetric ventricular hypertrophy with subsequent diastolic dysfunction and a complex and multifactorial pathogenesis where underlying biological mechanisms remain partly undefined. In this paper, we reviewed the key evidence available on the biological and clinical significance of micro-RNAs (miRNAs) in UCM. miRNAs are short, noncoding RNA molecules with regulatory functions that play a pivotal role in myriad basic cellular processes, such as cell growth and differentiation. Deranged miRNAs expression has already been observed in various diseases, and their capacity to modulate cardiac remodeling and fibrosis under either physiological or pathological conditions is well acknowledged. In the context of UCM, robust experimental evidence confirms a close involvement of some miRNAs in the key pathways that are known to trigger or worsen ventricular hypertrophy or fibrosis. Moreover, very preliminary findings may set the stage for therapeutic interventions targeting specific miRNAs for ameliorating heart damage. Finally, scant but promising clinical evidence may suggest a potential future application of circulating miRNAs as diagnostic or prognostic biomarkers for improving risk stratification in UCM as well.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCardiomyopathiesRNA, Small UntranslatedHumansFibrosisHeartHypertrophy

Stichwörter der Autor:innen

cardiac fibrosischronic kidney diseaseend-stage kidney diseasemiRNAuremic cardiomyopathyventricular hypertrophy

Substanzen

MicroRNAsRNA, Small Untranslated

Autor:innen und Institutionen

  • Nephrology and Dialysis Unit, Department of Medical and Surgical Sciences, University "Magna-Graecia" of Catanzaro, Viale Europa SNC, 88100 Catanzaro, Italy.

ORCID-Profile: Nazareno Carullo, Marta Greco, Michele Andreucci, Giuseppe Coppolino, Davide Bolignano

Zitieren

APA

D'Agostino, M., Mauro, D., Zicarelli, M., Carullo, N., Greco, M., Andreucci, M., Coppolino, G., & Bolignano, D. (2023). miRNAs in Uremic Cardiomyopathy: A Comprehensive Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065425

Vancouver

D'Agostino M, Mauro D, Zicarelli M, Carullo N, Greco M, Andreucci M, et al. miRNAs in Uremic Cardiomyopathy: A Comprehensive Review. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065425

BibTeX
@article{DAgostino2023,
  author = {D'Agostino, Mario and Mauro, Davide and Zicarelli, Mariateresa and Carullo, Nazareno and Greco, Marta and Andreucci, Michele and Coppolino, Giuseppe and Bolignano, Davide},
  title = {miRNAs in Uremic Cardiomyopathy: A Comprehensive Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065425}
}
Kostenlos starten →